Headline News about Incannex Healthcare Inc. - Common Stock
Psychedelic Drug Stocks Dragged Down By 83% Collapse In SEEL Stock Price
September 24, 2023
Via Talk Markets
4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week
September 17, 2023
Via Talk Markets
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
September 11, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Incannex preparing psilocybin therapy FDA IND application
August 24, 2023
Via News Direct
Exposures
Product Safety
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
Incannex To Prepare FDA IND Application For Psilocybin-Assisted Psychedelic Psychotherapy
August 24, 2023
Via Benzinga
Exposures
Product Safety
Incannex full steam ahead towards sleep apnoea trial
August 23, 2023
Via News Direct
Topics
Cannabis
FDA Approves Clinical Trial Of Incannex's Dronabinol-Based Drug For Obstructive Sleep Apnea
August 22, 2023
Via Benzinga
Exposures
Product Safety
Via Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
August 17, 2023
Via Benzinga
Via Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
August 16, 2023
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
Via Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 4, 2023
August 04, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.